Shanghai Henlius Biotech: Cancer Cell Published the Results of ASTRUM-004 - HANSIZHUANG Combined with Chemotherapy for the First-line Treatment of sqNSCLC

ASTRUM-004, a phase 3 clinical study of HANSIZHUANG plus chemotherapy for sqNSCLC, was published in Cancer Cell. The study showed that serplulimab in combination with chemotherapy significantly improved survival in [...]